Premium
Adenocarcinoma of the small bowel
Author(s) -
Hutchins Robert R.,
Hani Ahmed Bani,
Kojodjojo Pipin,
Ho Robyn,
Snooks Steven J.
Publication year - 2001
Publication title -
anz journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 70
eISSN - 1445-2197
pISSN - 1445-1433
DOI - 10.1046/j.1440-1622.2001.02149.x
Subject(s) - medicine , adenocarcinoma , incidence (geometry) , curative treatment , treatment modality , colorectal cancer , cancer , general surgery , disease , adjuvant therapy , surgery , physics , optics
Cancer of the small bowel is a rare entity but its incidence is rising. Historically, outcome is poor despite apparent curative resection. At present surgery remains the only treatment modality of proven benefit in the management of this disease. Recent data would suggest 5‐year survival rates in the order of 40–50% at all sites of small bowel cancer. To improve upon this, earlier diagnosis with a high index of suspicion and multicentre adjuvant therapy trials are required.